878804-93-4

Usage

Uses

Used in Organic Synthesis:
2-Pyridinamine, 3-(difluoromethyl)is used as a building block for the creation of other complex organic molecules, contributing to the development of new compounds with various applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Pyridinamine, 3-(difluoromethyl)is utilized for its potential applications in the development of new drugs. Its unique structure and functional groups make it a promising candidate for designing innovative therapeutic agents.
Used in Agrochemical Development:
2-Pyridinamine, 3-(difluoromethyl)may also have potential applications in the agrochemical sector, where it could be employed in the development of new pesticides or other agricultural chemicals to improve crop protection and yield.

Upstream product

• 36404-88-3 2-chloro-3-carbaldehydepyridine 
• 1620575-09-8 3-(difluoromethyl)-N-(diphenylmethylene)pyridin-2-amine 
• 865663-96-3 2-chloro-3-(difluoromethyl)pyridine 

Relevant academic research and scientific papers

3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS

The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. (I) In compounds of Formula I, the groups R1, R2, R3, R4, R5, R6 and R7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders.

NOVEL SUBSTITUTED IMIDAZOLE DERIVATIVES

The present invention relates to a compound represented by Formula [I] or a pharmaceutically acceptable salt or ester thereof: wherein: X1, X2, X3, and X4, which may be identical or different, are each C or N, provided that none to two of X1, X2, X3, and X4 is/are N; Y is CH or N; R1, R1', R2, R2', R3, R3', R4, and R4', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R5 is a hydrogen atom or a methyl group; R6 and R7, which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R8 and R8', which may be identical or different, are each a hydrogen atom, a lower alkyl group, or the like; R9 is an aryl group or a heteroaryl group which may be substituted; and n is an integer from 1 to 3, and a PLK1 inhibitor or an anticancer agent containing the same.